| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.0081 | 0.9 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |